# Extracorporeal membrane oxygenation with single-site dual-lumen in a patient with SARS-CoV-2–associated acute respiratory distress syndrome: a case report

**Authors:** Dongmei Hu, Yingdian Yu

PMC · DOI: 10.3389/fmed.2026.1772996 · Frontiers in Medicine · 2026-03-04

## TL;DR

A critically ill elderly patient with severe SARS-CoV-2-induced ARDS was successfully treated using a single-site dual-lumen ECMO cannula and early rehabilitation, leading to a favorable outcome.

## Contribution

This case demonstrates the feasibility of using a single-site dual-lumen cannula for awake ECMO combined with early rehabilitation in severe ARDS.

## Key findings

- The patient achieved a favorable outcome despite high predicted mortality.
- The single-site dual-lumen cannula enabled unrestricted physiotherapy and early mobilization.
- The approach requires expert execution and carries risks like bleeding and P-SILI.

## Abstract

This case report describes the successful management of a critically ill elderly patient with severe SARS-CoV-2-associated acute respiratory distress syndrome (ARDS) using an integrated strategy of awake veno-venous extracorporeal membrane oxygenation (VV-ECMO) via a single-site, dual-lumen cannula (SDLC) combined with a protocolized early rehabilitation programme. Despite high predicted mortality based on validated prognostic scores, the patient achieved a favorable outcome. The SDLC, inserted via the right internal jugular vein, was instrumental as a technological enabler. By providing unobstructed access to the lower limbs, it permitted unrestricted physiotherapy and early mobilization, which is vital for preserving musculoskeletal and neurocognitive function, supporting nutrition, and enhancing patient autonomy. Furthermore, a single puncture site reduces infectious risks and simplifies care compared to traditional multi-cannula configurations. However, this approach demands flawless technical execution, mandating real-time transesophageal echocardiography (TEE) guidance for precise cannula positioning to avoid recirculation or myocardial injury, and often requires intensified anticoagulation, increasing bleeding risk. The awake ECMO strategy deliberately harnesses spontaneous breathing to promote lung recruitment while facilitating ultra-protective ventilation, though it necessitates careful monitoring to mitigate the risk of patient self-inflicted lung injury (P-SILI). For carefully selected patients requiring prolonged support, the triad of SDLC VV-ECMO, an awake strategy, and early rehabilitation is a feasible and advantageous approach that shifts the treatment goal from mere survival to functional survival. It should be employed in expert centers, and future research is needed to standardize protocols and validate long-term outcomes.

## Linked entities

- **Diseases:** SARS-CoV-2 (MONDO:0100096), acute respiratory distress syndrome (MONDO:0006502), ARDS (MONDO:0006502)

## Full-text entities

- **Diseases:** lung injury (MESH:D055370), critically ill (MESH:D016638), infectious (MESH:D003141), ARDS (MESH:D012128), myocardial injury (MESH:D009202), bleeding (MESH:D006470)
- **Chemicals:** Extracorporeal (-)
- **Species:** Homo sapiens (human, species) [taxon 9606], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12996247/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12996247/full.md

## References

17 references — full list in the complete paper: https://tomesphere.com/paper/PMC12996247/full.md

---
Source: https://tomesphere.com/paper/PMC12996247